0
0
0
VALID Act of 2020
2/8/2022, 11:16 PM
Congressional Summary of HR 6102
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020
This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
Read the Full Bill
Current Status of Bill HR 6102
Bill HR 6102 is currently in the status of Bill Introduced since March 5, 2020. Bill HR 6102 was introduced during Congress 116 and was introduced to the House on March 5, 2020. Bill HR 6102's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 5, 2020
Bipartisan Support of Bill HR 6102
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
0Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 6102
Primary Policy Focus
HealthPotential Impact Areas
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Federal preemption
- Food and Drug Administration (FDA)
- Government information and archives
- Health technology, devices, supplies
- Licensing and registrations
- Medical tests and diagnostic methods
- Performance measurement
- User charges and fees
Alternate Title(s) of Bill HR 6102
VALID Act of 2020
To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
VALID Act of 2020
Verifying Accurate Leading-edge IVCT Development Act of 2020
Comments
Sponsors and Cosponsors of HR 6102
Latest Bills
Financial Reporting Threshold Modernization Act
Bill HR 1799January 24, 2026
Expressing support for the designation of May 2025 as "Renewable Fuels Month" to recognize the important role that renewable fuels play in reducing carbon impacts, lowering fuel prices for consumers, supporting rural communities, and lessening reliance on foreign adversaries.
Bill HRES 375January 24, 2026
Empower Charter School Educators to Lead Act
Bill HR 3453January 24, 2026
Star-Spangled Summit Act of 2025
Bill HR 4684January 23, 2026
Cross-Boundary Wildfire Solutions Act
Bill HR 3922January 23, 2026
Whole Milk for Healthy Kids Act of 2025
Bill S 222January 23, 2026
Retire through Ownership Act
Bill HR 5169January 23, 2026
No Tax on Home Sales Act
Bill HR 4327January 23, 2026
MAWS Act of 2025
Bill HR 4294January 23, 2026
Enhanced Iran Sanctions Act of 2025
Bill HR 1422January 23, 2026
VALID Act of 2020
Bill S 3404February 8, 2022